Author:
Liu Bao-cheng,He Lin,He Guang,He Yun
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference25 articles.
1. Storlk, P., Willemen, M.J. and Leufkens, H.G. (2006) Rare essentials: Drugs for rare diseases as essential medicines. Bulletin of the World Health Organization 84: 745–751.
2. Baudrihaye, N. (1994) Toward an orphan drug policy for Europe. European Commission. Brussels, Belgium: European Union.
3. Schieppati, A., Henter, J.I., Daina, E. and Aperia, A. (2008) Why rare diseases are an important medical and social issue. Lancet 371: 2039–2041.
4. Haffner, M.E. (2006) Adopting orphan drugs – Two dozen years of treating rare diseases. New England Journal of Medicine 354: 445–447.
5. Cheung, R.Y., Cohen, J.C. and Illingworth, P. (2004) Orphan drug policies: Implications for the United States, Canada, and developing countries. Health Law Journal 12: 183–200.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献